RELINT: FPH: Disclosure of Directors and Officer Relevant Interests
10 Jun 2010 3:58 pm
FPH
10/06/2010
RELINT
REL: 1558 HRS Fisher & Paykel Healthcare Corporation Limited
RELINT: FPH: Disclosure of Directors and Officer Relevant Interests
A Details of director or officer
Name of director or officer of public issuer: William Lindsay
GILLANDERS
Name of public issuer: Fisher & Paykel Healthcare Corporation
Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Director
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities: 6,840 ordinary shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial
Name of registered holder of securities Gillanders Family
Trust
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of transfer 3 June 2010
Consideration paid for transfer NZ$Nil
If the relevant interest was disposed of--
Date of disposal: Not Applicable
Consideration paid for disposal: Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the transfer took place: 8 Transfer 6,840 ordinary shares from
Gillanders Family Trust to L R S Management Ltd, trustee of family trust
E Total number of transactions this notice relates to: One
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 10 2 June 2006
A Details of director or officer
Name of director or officer of public issuer: Gary Albert PAYKEL
Name of public issuer: Fisher & Paykel Healthcare Corporation
Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Chairman
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities: 6,840 ordinary shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Non-Beneficial
Name of registered holder of securities Gillanders Family
Trust
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of transfer 3 June 2010
Consideration paid for issue NZ$Nil
If the relevant interest was disposed of--
Date of disposal: Not Applicable
Consideration paid for disposal: Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the issue took place: Transfer of 6,840 ordinary shares from
Gillanders Family Trust to LRS Management Ltd, non-beneficial trustee of the
Gillanders Family Trust
E Total number of transactions this notice relates to: One
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 10 June 2010
A Details of director or officer
Name of director or officer of public issuer: Michael Robert BATTY
Name of public issuer: Fisher & Paykel Healthcare Corporation
Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Group Operations Manager
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: 8,300 ordinary shares
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial interest
Name of registered holder of securities Michael Robert BATTY
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: N/A
Consideration paid for acquisition: N/A
If the relevant interest was disposed of--
Date of Transfer 3 June 2010
Consideration paid for transfer: NZ$Nil
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place: Transfer of 8,300
ordinary shares from own name to wife
E Total number of transactions this notice relates to: One
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 11 September 2009
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as
available. Information and documents given to ASX become ASX's property and
may be made public.
Introduced 30/9/2001.
Name of entity: FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
ABN: 098 026 281
We (the entity) give ASX the following information under listing rule 3.19A.2
and as agent for the director for the purposes of section 205G of the
Corporations Act.
Name of Director GARY ALBERT PAYKEL
Date of last notice 5 January 2010
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available
by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of
the definition of "notifiable interest of a director" should be disclosed in
this part.
Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest. N/A
Date of change 3 June 2010
No. of securities held prior to change o ANDSAR Family Trust - Trustee
of Family Trust - 2,022,635 Ordinary Shares
o Gillanders Family Trust - Trustee of a Family Trust - 6,840 Ordinary
Shares
o Maurice Paykel Charitable Trust Inc - Trustee of a Family Charitable
Trust - 247,608 Ordinary Shares
o Maurice & Phyllis Paykel Trust Inc - Trustee of a Family Charitable
Trust - 1,614,587 Ordinary Shares
o Fisher & Paykel Healthcare Employee Share Purchase Trustee Ltd -
Director of Trustee Company - 821,640 Ordinary Shares.
Class Ordinary shares
Number acquired 6,840 ordinary shares
Number disposed 6,840 ordinary shares
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
NZ$Nil
No. of securities held after change o ANDSAR Family Trust - Trustee
of Family Trust - 2,022,635 Ordinary Shares
o Gillanders Family Trust - Trustee of a Family Trust - Nil Ordinary
Shares
o Maurice Paykel Charitable Trust Inc - Trustee of a Family Charitable
Trust - 247,608 Ordinary Shares
o Maurice & Phyllis Paykel Trust Inc - Trustee of a Family Charitable
Trust - 1,614,587 Ordinary Shares
o Fisher & Paykel Healthcare Employee Share Purchase Trustee Ltd -
Director of Trustee Company - 821,640 Ordinary Shares.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
o Transfer of 6,840 ordinary shares from Gillanders Family Trust to LRS
Management Ltd, non-beneficial trustee of the Gillanders Family Trust
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of
the definition of "notifiable interest of a director" should be disclosed in
this part.
Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the
interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated
valuation
Interest after change
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as
available. Information and documents given to ASX become ASX's property and
may be made public.
Introduced 30/9/2001.
Name of entity Fisher & Paykel Healthcare Corporation Limited
ABN 098 026 281
We (the entity) give ASX the following information under listing rule 3.19A.2
and as agent for the director for the purposes of section 205G of the
Corporations Act.
Name of Director William Lindsay GILLANDERS
Date of last notice 2 June 2006
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available
by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of
the definition of "notifiable interest of a director" should be disclosed in
this part.
Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
N/A
Date of change 3 June 2010
No. of securities held prior to change 507,575 Ordinary Shares L R S
Management Ltd - Trustee of a Family Trust
6,840 Ordinary Shares Gillanders Family Trust - Trustee of a Family Trust
Class Ordinary shares
Number acquired 6,840 ordinary shares
Number disposed 6,840 ordinary shares
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
NZ$Nil
No. of securities held after change 514,415 Ordinary Shares L R S
Management Ltd - Trustee of a Family Trust
Nil Ordinary Shares Gillanders Family Trust - Trustee of a Family Trust
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Transfer of 6,840 from Gillanders Family Trust to L R S Management (Trustee
of family trust).
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of
the definition of "notifiable interest of a director" should be disclosed in
this part.
Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the
interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated
valuation
Interest after change
End CA:00195957 For:FPH Type:RELINT Time:2010-06-10:15:58:57 More announcements for FPH
|
|


NZX 15 Index
| |
FREE Email News
Today's Market Numbers
| NZX 50 Index |
3348.13 |
 |
21.40 |
| S&P/ASX 200 |
4255.60 |
 |
27.30 |
| Dow Jones Industrials |
12890.50 |
 |
6.50 |
Stock Quote
Most Commented On
|